Is Cobicistat Tablet (Tybost) in shortage?
Cobicistat Tablet is listed by FDA as being discontinued by at least one maker (updated Oct 7, 2025).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Tybost, Tablet, 150 mg (NDC 61958-1401-1)
Gilead plans to sell through the end of February 2026. Discontinuation of the manufacture of the drug due to business reasons.
Maker contact: 800-445-3235
Other forms on FDA’s list
Cobicistat Tablet shortage questions
Is Cobicistat Tablet (Tybost) in shortage?
Cobicistat Tablet is listed by FDA as being discontinued by at least one maker (updated Oct 7, 2025).
What should I do if I can’t get Cobicistat Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.